PR610

· Proacta, Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PR610, covering 2014-06-16 to 2014-06-16. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors [Phase 1, Phase 2]